aTyr Pharma | LIFE - Los Gastos De Explotación





Los Gastos De Explotación Cambio Fecha
Alterity Therapeutics Limited AUD 8.67M 893.38K 2025-12
Ardelyx USD 133.3M 6.04M 2026-06
aTyr Pharma USD 2.55M 126.72K 2026-06
Biogen USD 2.32B 663.6M 2026-09
Bristol-Myers Squibb USD 23.4B 1.08B 2026-09
Cipla INR 63.61B 1.3B 2026-09
Clal Biotechnology ILS 5.15M 9.47M 2022-12
Compugen USD 11.44M 246K 2026-06
CSL USD 5.7B 2.82B 2025-12
Curis USD 11.52M 2.5M 2026-03
GlaxoSmithKline GBP 6.03B 227M 2026-09
Grifols EUR 1.99B 217.4M 2025-12
Lakefront Biotherapeutics EUR 55.62M 14.56M 2026-06
Novartis USD 9.88B 325M 2026-09
Roche Holding CHF 18.9B 2.12B 2026-06
United Therapeutics USD 6.28B 124.3M 2026-09